CanSino Biologics Inc. (HKG:6185)
Hong Kong · Delayed Price · Currency is HKD 33.94
+1.74 (5.40%)
At close: Mar 6, 2026
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 13.81 billion as of March 6, 2026. Its market cap has increased by 19.80% in one year.
Market Cap
13.81B
Enterprise Value
12.29B
Revenue
1.19B
Ranking
n/a
PE Ratio
277.27
Stock Price
33.94
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 7.57B to 13.81B, an increase of 82.44%. That is a compound annual growth rate of 9.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 13.81B | 9.35% |
| Dec 31, 2025 | 12.63B | 8.81% |
| Dec 31, 2024 | 11.61B | -7.23% |
| Dec 29, 2023 | 12.51B | -54.81% |
| Dec 30, 2022 | 27.69B | -58.12% |
| Dec 31, 2021 | 66.11B | -11.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OneRobotics (Shenzhen) | 24.40B |
| Sunshine Lake Pharma | 23.77B |
| Ab&B Bio-Tech CO., LTD. JS | 20.52B |
| CF PharmTech | 15.22B |
| Consun Pharmaceutical Group | 14.30B |
| Sihuan Pharmaceutical Holdings Group | 12.62B |
| Shandong Xinhua Pharmaceutical Company | 9.92B |
| Luye Pharma Group | 9.79B |